Sela represents emerging and high-growth companies through all stages of the corporate life cycle – from formation and funding to mergers and acquisitions and public offerings. Additionally, she provides guidance on corporate governance issues and advises venture capital clients on financing transactions.
Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck
October 14, 2024
Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.
